Kreftregisteret

Public Health Registry Serviceskreftregisteret.no

Kreftregisteret is Norway's national cancer registry under the Norwegian Institute of Public Health, collecting statutory cancer data since 1951 and operating three national screening programs (mammography, cervical, colorectal) for clinicians, researchers, and the public.

Company typePrivate
Founded1951
HeadquartersOslo, Norway
Headcount101–250
GTM typeB2B
OfferingServices

What Kreftregisteret does

Kreftregisteret (Cancer Registry of Norway) is the national population-based cancer registry of Norway, operated as a government entity under Folkehelseinstituttet (the Norwegian Institute of Public Health; Org.nr 983 744 516). Founded in 1951 and headquartered in Oslo, the organization collects, processes, and analyzes cancer data from across Norway, providing cancer statistics, treatment quality monitoring, and research data access to clinicians, researchers, and policymakers. Healthcare providers are mandated to report cancer cases, giving the registry a comprehensive national dataset spanning over 70 years of incidence, treatment, and survival outcomes.

The registry's product surface is built around a core cancer registry data platform and three organized national screening programs: Mammografiprogrammet (Mammography), Livmorhalsscreeningprogrammet (Cervical), and Tarmscreeningprogrammet (Bowel/Colorectal). It also operates the Janus Serumbank biobank, a set of quality registries for cancer care (Kvalitetsregistrene på kreftområdet), a cancer statistics and data release service, and the annual "Cancer in Norway" publication. Together these constitute an integrated cancer surveillance and early-detection platform serving public health planning and epidemiological research. Director Giske Ursin leads the organization, which employs 101–250 staff.

Kreftregisteret is funded through the Norwegian state budget as part of public health infrastructure under FHI; it does not charge commercial prices for its services, has no disclosed funding rounds, and operates as a statutory monopoly on comprehensive national cancer data. Customer segments — healthcare providers as data reporters, cancer researchers as data consumers, and the general population as screening participants — are accessed via official government channels rather than commercial GTM motions.

Kreftregisteret firmographics

Firmographics

Name: Kreftregisteret
Legal name: Kreftregisteret
Website: https://kreftregisteret.no
Company type: Private
Founded year: 1951
Operating status: Operating
Headcount range: 101–250 employees
Short description: Kreftregisteret is Norway's national cancer registry under the Norwegian Institute of Public Health, collecting statutory cancer data since 1951 and operating three national screening programs (mammography, cervical, colorectal) for clinicians, researchers, and the public.
Ownership category
akta.pro rank

Kreftregisteret industry classification

Industry

Product category: Public Health Registry Services
NAICS: Web Search Portals, Libraries, Archives, and Other Information Services (5192), Libraries and Archives (51921)
akta.pro primary industry: Disease Registries (Cancer, Immunization, Rare Disease, etc.) (HLAJAJAE)
akta.pro secondary industries: Patient Registries & Chronic Disease Registry Analytics (HLACAHAH), Public Health Reporting, Dashboards & KPI Performance Management (HLAJANAO), Public Health Data Governance, Privacy & Information Management (HLAJAMAI)

Keywords

Cancer registry services
Cancer screening programs
Epidemiological data
Health data registry
Cancer statistics

Where Kreftregisteret is headquartered

Location

Headquarters

HQ city: Oslo
HQ country: Norway
HQ region: Europe

Markets served

Kreftregisteret business model

Business model

GTM type: B2B
Offering type: Services
Cost components: Personnel, Operations, Technology or R&D, Infrastructure

Kreftregisteret product offering

Product offering

Core offering

Kreftregisteret (Cancer Registry of Norway) is a national population-based health registry that collects, processes, and analyzes cancer data across Norway. It operates three organized national screening programs (Mammography, Cervical, and Colorectal), maintains the Janus Serumbank biobank, runs quality registries monitoring cancer diagnosis and treatment outcomes, and publishes annual cancer statistics including the Cancer in Norway report.

Product overview

Kreftregisteret (Cancer Registry of Norway) is a national health registry operated by the Norwegian Institute of Public Health (Folkehelseinstituttet). It operates as a platform of interconnected cancer registry services comprising the core Cancer Registry data infrastructure, three organized screening programs (Mammografiprogrammet, Livmorhalsscreeningprogrammet, and Tarmscreeningprogrammet), research resources like Janus Serumbank, quality registries for monitoring care outcomes, statistical reporting services, and the Cancer in Norway annual publication. The registry serves as the centralized hub for cancer surveillance, early detection screening, epidemiological research, and health data provision across Norway.

Differentiator

Problem solved

Functional benefit

Brands

Mammografiprogrammet (Mammography Screening Programme): National mammography screening programme for breast cancer detection
Livmorhalsprogrammet (Cervical Screening Programme)
Tarmscreeningprogrammet (Bowel Screening Programme)
Janus Serumbank

Products and services

Kreftregisteret (Cancer Registry of Norway) National population-based cancer registry that collects, processes, and analyzes cancer data across Norway, serving as a foundational resource for cancer research, public health planning, and epidemiological studies. Targeted at healthcare providers, researchers, and government public health authorities.
Mammografiprogrammet (Mammography Screening Program) Organized screening program for early detection of breast cancer, offering mammography examinations to the target population of women in Norway. Targeted at the general female population eligible for breast cancer screening.
Livmorhalsscreeningprogrammet (Cervical Screening Program) National screening program for early detection and prevention of cervical cancer, providing regular screening tests to women in Norway. Targeted at the general female population eligible for cervical cancer screening.
Tarmscreeningprogrammet (Bowel Screening Program) Organized screening program for early detection of colorectal cancer, offering screening tests to the target population in Norway. Targeted at the general population eligible for colorectal cancer screening.
Janus Serumbank (Janus Serum Bank) Biobank containing serum samples collected from the Norwegian population, supporting cancer research and epidemiological studies. Targeted at cancer researchers and academic institutions.
Kvalitetsregistrene på kreftområdet (Quality Registries in Cancer) Quality registries that monitor and report on the quality of cancer diagnosis, treatment, and care outcomes across Norway. Targeted at healthcare providers and public health authorities.
Kreftstatistikk og datautlevering (Cancer Statistics and Data Release) Statistical reporting service providing cancer data, trends, and analysis to researchers, healthcare professionals, and the public. Targeted at cancer researchers, healthcare professionals, and public health planners.

Companies that use Kreftregisteret

Customer profile

Segments3 records

Ideal customer profiles3 records

Kreftregisteret technology and API

Technology

Technology focussed Yes

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Kreftregisteret partnerships and signals

Strategic signal

Recent moves1 record

Expansion highlights3 records

Kreftregisteret competitors and assessment

Company assessment

Broad incumbents

European Cancer Information System (ECIS): EU-wide cancer data platform operated by the European Commission/JRC, integrating national registry data for cross-country surveillance; a broad incumbent that consumes and complements Kreftregisteret's outputs.
International Agency for Research on Cancer (IARC): WHO agency that coordinates international cancer registry collaboration (including the CI5 series) and harmonizes global cancer statistics; a broader incumbent that aggregates outputs from national registries including Kreftregisteret.

Direct peers

National Cancer Registration and Analysis Service (NCRAS, England): England's national cancer registry operated by NHS Digital, collecting population-level cancer data for surveillance, outcomes research, and service planning — a direct peer in mission and stakeholder mix.
SEER (Surveillance, Epidemiology, and End Results Program): U.S. National Cancer Institute program that collects population-based cancer registry data on incidence, treatment, and survival; directly comparable as a national cancer surveillance system serving research and public health stakeholders.
Danish Cancer Registry: Denmark's national cancer registry under the Danish Health Data Authority; comparable Nordic cancer surveillance system with mandatory reporting and integrated research access.
Finnish Cancer Registry: Population-based national cancer registry of Finland, operating under similar Nordic statutory mandates and providing epidemiological statistics, screening program data, and research access — highly comparable in scale and mission.
Swedish National Cancer Registry: Sweden's national population-based cancer registry maintained by the National Board of Health and Welfare; a direct Nordic peer with mandatory reporting and similar epidemiological research outputs.

Emerging players

NordCan: Collaborative Nordic cancer statistics portal combining data from the Nordic cancer registries (including Norway, Sweden, Finland, Denmark); a peer collaboration platform that both competes with and depends on Kreftregisteret's data.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights5 records

Customer concentration

Kreftregisteret financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Kreftregisteret leadership team

Management profile

Number of profiles

Profiles1 record

Kreftregisteret funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Kreftregisteret M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kreftregisteret

What does Kreftregisteret do?

Is Kreftregisteret a public or private company?

Kreftregisteret is a private company. It is classified as state government owned and is currently operating.

When was Kreftregisteret founded?

Kreftregisteret was founded in 1951. It employs 101 to 250 people.

Where is Kreftregisteret based?

Kreftregisteret is headquartered in Oslo, Norway, in the Europe region.

Who are Kreftregisteret's main competitors?

Broad incumbents on record are European Cancer Information System (ECIS) and International Agency for Research on Cancer (IARC). Direct peers are National Cancer Registration and Analysis Service (NCRAS, England), SEER (Surveillance, Epidemiology, and End Results Program), Danish Cancer Registry, Finnish Cancer Registry and Swedish National Cancer Registry. NordCan is listed as an emerging player.

Does Kreftregisteret have an API?

No public API is recorded for Kreftregisteret.

What industry is Kreftregisteret in?

Kreftregisteret's product category is Public Health Registry Services. Its primary akta.pro industry code is HLAJAJAE, Disease Registries (Cancer, Immunization, Rare Disease, etc.), with a secondary code of HLACAHAH, Patient Registries & Chronic Disease Registry Analytics. Its NAICS code is 5192.